Skip to main content
SpringerLink
Log in

68Ga-PSMA ligand PET versus 18F-NaF PET: evaluation of response to 223Ra therapy in a prostate cancer patient

  • Image of the Month
  • Published:
European Journal of Nuclear Medicine and Molecular Imaging Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Parker C, Nilsson S, Heinrich D, Helle SI, O’Sullivan JM, Fossa SD, et al. Alpha emitter radium-223 and survival in metastatic prostate cancer. N Engl J Med. 2013;369(3):213–23.

    Article  CAS  PubMed  Google Scholar 

  2. Lawrentschuk N, Davis ID, Bolton DM, Scott AM. Diagnostic and therapeutic use of radioisotopes for bone disease in prostate cancer: current practice. Int J Urol. 2007;14(2):89–95.

    Article  CAS  PubMed  Google Scholar 

  3. Afshar-Oromieh A, Haberkorn U, Eder M, Eisenhut M, Zechmann C. [68Ga]Gallium-labelled PSMA ligand as superior PET tracer for the diagnosis of prostate cancer: comparison with 18F-FECH. Eur J Nucl Med Mol Imaging. 2012;39(6):1085–6.

    Article  CAS  PubMed  Google Scholar 

  4. Van Schelven WD, Pauwels EK. The flare phenomenon: far from fair and square. Eur J Nucl Med. 1994;21(5):377–80.

    Article  PubMed  Google Scholar 

Download references

Conflicts of interest

None.

Author information

Authors and Affiliations

  1. Department of Nuclear Medicine, Medical University Innsbruck, Anichstrasse 35, Innsbruck, Austria

    Christian Uprimny, Alexander Kroiss, Bernhard Nilica, Sabine Buxbaum, Clemens Decristoforo & Irene J. Virgolini

  2. Department of Urology, Medical University Innsbruck, Anichstrasse 35, Innsbruck, Austria

    Wolfgang Horninger

Authors
  1. Christian Uprimny
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alexander Kroiss
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Bernhard Nilica
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Sabine Buxbaum
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Clemens Decristoforo
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Wolfgang Horninger
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Irene J. Virgolini
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Christian Uprimny.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Uprimny, C., Kroiss, A., Nilica, B. et al. 68Ga-PSMA ligand PET versus 18F-NaF PET: evaluation of response to 223Ra therapy in a prostate cancer patient. Eur J Nucl Med Mol Imaging 42, 362–363 (2015). https://doi.org/10.1007/s00259-014-2922-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00259-014-2922-4

Keywords

Search

Navigation